Treatment for COVID-19

The FDA has approved remdesivir, an antiviral drug, for use in adults and children aged 12 years or older for the treatment of COVID-19 requiring hospitalization. The use of remdesivir in children younger than 12 years is still being evaluated. Other medications are also being evaluated as potential treatments for COVID-19. Please consult a licensed physician or other healthcare provider for additional recommendations about disease treatment.

Remdesivir is an antiviral drug being studied as a treatment for COVID-19. Gilead Sciences Inc., the pharmaceutical company that makes remdesivir, received approval from the U.S. Food and Drug Administration on October 22, 2020 to allow the medication to be utilized by hospitalized COVID-19 patients who are adults and children aged 12 years or older.Children younger than 12 years of age may receive remdesivir through an Emergency Use Authorization (EUA).

Yes. Other antiviral medications are being studied to see if they might help treat COVID-19. Therapies directed at a person’s immune system are also under study. The use of convalescent plasma, which involves taking the plasma from a person who has recovered from COVID-19 and infusing it into a person with the illness, is being studied. For information on how to donate plasma if you have recovered from COVID-19, please see information from the FDA here. For more information about therapies under investigation, please see here.

Monoclonal antibodies are antibodies (proteins) made in a laboratory. They come from patients who have successfully recovered from an infection by mounting an immune response. Antibodies are proteins made by a person's immune system to fight an infection. Antibodies bind to the virus (or other type of germ) to prevent entry into a person’s cells.

There are clinical trials underway to see if monoclonal antibodies are safe and effective at preventing or treating COVID-19. For more information about monoclonal antibodies and COVID-19, visit the National Institutes of Health (NIH) websites here.

If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma. Because you fought the infection, your plasma now contains COVID-19 antibodies. These antibodies provided one way for your immune system to fight the virus when you were sick, so your plasma may be able to be used to help others fight off the disease.

For more information on convalescent plasma, eligibility, and where to donate, click here. The FDA also has information on plasma donation here.

There is currently no scientific evidence to show that taking ibuprofen while sick with COVID-19 will lead to worsening illness. For persons looking for a medication to reduce their fever, acetaminophen might be preferable. Both acetaminophen and ibuprofen, like any other medication, can have serious side effects. You should consult with your healthcare provider if you are unsure what the best medication is for you.

No, it is not.  Drinking or injecting bleach is VERY dangerous and can cause serious illness or death. Please consult a licensed physician or other healthcare provider for treatment recommendations.

Page last reviewed: November 19, 2020